Costamare Bulkers Holdings Limited (CMDB)
NYSE: CMDB · Real-Time Price · USD
19.61
-0.41 (-2.05%)
Oct 30, 2026, 4:00 PM EDT - Market closed
CMDB Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 664.48 | 597.22 | 1,195 | 663.12 | 316.47 | |
Revenue Growth | -16.85% | -50.04% | 80.27% | 109.54% | - |
Cost of Revenue | 585.07 | 557.37 | 1,147 | 710.86 | 142.27 |
Gross Profit | 79.41 | 39.85 | 48.38 | -47.75 | 174.2 |
Selling, General & Admin | 36.93 | 30.29 | 48.44 | 41.78 | 27.08 |
Operating Expenses | 73.01 | 58.7 | 85.82 | 81.4 | 66.74 |
Operating Income | 6.4 | -18.85 | -37.45 | -129.15 | 107.46 |
Interest Expense | -9.92 | -9.03 | -25.3 | -26.51 | -18.83 |
Interest & Investment Income | 5.66 | 3.14 | 1.48 | 2.37 | - |
Currency Exchange Gain (Loss) | -0.33 | -0.3 | 0.01 | 0.43 | -0.18 |
Other Non Operating Income (Expenses) | 19.73 | 13.64 | -42.26 | 8.12 | -1.13 |
EBT Excluding Unusual Items | 21.54 | -11.4 | -103.52 | -144.74 | 87.32 |
Merger & Restructuring Charges | -20.12 | -14.5 | - | - | - |
Gain (Loss) on Sale of Assets | 2.85 | -11.46 | 3.79 | -7.63 | 3.45 |
Asset Writedown | - | - | - | -0.43 | -1.69 |
Other Unusual Items | - | - | 1.48 | 5.11 | 1.36 |
Pretax Income | 4.27 | -37.35 | -98.26 | -147.7 | 90.45 |
Net Income | 4.27 | -37.35 | -98.26 | -147.7 | 90.45 |
Net Income to Common | 4.27 | -37.35 | -98.26 | -147.7 | 90.45 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 24 | 16 | - | - | - |
Shares Outstanding (Diluted) | 24 | 16 | - | - | - |
Shares Change | 44.13% | - | - | - | - |
EPS (Basic) | 0.18 | -2.28 | - | - | - |
EPS (Diluted) | 0.18 | -2.28 | - | - | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 24.34 | 43.9 | -228.39 | -272.73 | 61.87 |
Free Cash Flow Per Share | 1.00 | 2.68 | - | - | - |
Gross Margin | 11.95% | 6.67% | 4.05% | -7.20% | 55.05% |
Operating Margin | 0.96% | -3.16% | -3.13% | -19.48% | 33.96% |
Profit Margin | 0.64% | -6.25% | -8.22% | -22.27% | 28.58% |
Free Cash Flow Margin | 3.66% | 7.35% | -19.11% | -41.13% | 19.55% |
EBITDA | 42.47 | 9.56 | -0.06 | -89.53 | 147.12 |
EBITDA Margin | 6.39% | 1.60% | -0.01% | -13.50% | 46.49% |
D&A For EBITDA | 36.07 | 28.41 | 37.39 | 39.62 | 39.66 |
EBIT | 6.4 | -18.85 | -37.45 | -129.15 | 107.46 |
EBIT Margin | 0.96% | -3.16% | -3.13% | -19.48% | 33.96% |
Revenue as Reported | 664.48 | 597.22 | 1,195 | 663.12 | - |